Diagnosis, Monitoring, and Management of Hepatitis C Virus

Question Title

* 1. Please enter your name as you would like it to appear on your CME certificate.

Question Title

* 2. Please select your title

Other (please specify)

Question Title

* 3. What is your specialty?

Question Title

* 4. Did you perceive any commercia bias associated with this activity?

Yes

Question Title

* 5. If you answered yes to the previous question, please describe perceived bias.

Question Title

* 6. When, if at any time, have you seen any patients presenting with acute HCV infection in the last year? (Please select all that apply)

I haven't seen any patients presenting with acute HCV infection in the last 12 months.

30 days or less

1-3 months

4-6 months

7-12 months

Question Title

* 7. Please rate your comfort level in treating patients with HCV.

Not comfortable at all

Somewhat comfortable

Neutral

Very comfortable

Not comfortable at all

Somewhat comfortable

Neutral

Very comfortable

Question Title

* 8. Have you encountered any barriers with pre-authorization related to the treatment of HCV?

Yes

Not applicable to me/my practice

Question Title

* 9. What new strategies will you implement as a result of your participation in this activity? (Please check all that apply.)

Apply new screening guidelines for patients

Apply new treatment approaches

Modify how I communicate with patients

I don't plan to make any changes at this time

Other (please specify)

Question Title

* 10. What barriers do you perceive to implementing new strategies or treatment plans?

Patient non-adherence to treatment plan

Cost

Patient concerns regarding stigmas

Prior authorization

None of the above

Other (please specify)

Diagnosis, Monitoring, and Management of Hepatitis C Virus

Question Title

* 1. Please enter your name as you would like it to appear on your CME certificate.

Question Title

* 2. Please select your title

Question Title

* 3. What is your specialty?

Question Title

* 4. Did you perceive any commercia bias associated with this activity?

Question Title

* 5. If you answered yes to the previous question, please describe perceived bias.

Question Title

* 6. When, if at any time, have you seen any patients presenting with acute HCV infection in the last year? (Please select all that apply)

Question Title

* 7. Please rate your comfort level in treating patients with HCV.

Question Title

* 8. Have you encountered any barriers with pre-authorization related to the treatment of HCV?

Question Title

* 9. What new strategies will you implement as a result of your participation in this activity? (Please check all that apply.)

Question Title

* 10. What barriers do you perceive to implementing new strategies or treatment plans?

Question Title

* 11. What other educational content can KMA provide to support your professional development?